IndraLab

Statements


USP9X activates KRAS-G12D. 2 / 2
| 2

reach
"In these models, genetic inactivation of Usp9x (either by insertional mutagenesis or Pdx1-Cre mediated deletion) was found to enhance oncogenic Kras G12D in accelerating tumourogenesis and cancer progression [XREF_BIBR]."

reach
"The FAM labelled probe targeted the KRAS G12D allele, while the CAL Fluor Orange560 labeled probe (VIC alternative probe) targeted the WT allele."